4-(4-chlorophenyl)-N-(3-methoxyphenyl)thiazol-2-amine | 340690-10-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-chlorophenyl)-N-(3-methoxyphenyl)thiazol-2-amine
• 英文别名: 4-(4-chlorophenyl)-N-(3-methoxyphenyl)-1,3-thiazol-2-amine
• CAS: 340690-10-0
• 化学式: C₁₆H₁₃ClN₂OS
• mdl: MFCD00747130
• 分子量: 316.811
• InChiKey: ACXKDXTUVJOMKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  62.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  1-(1-azido-2-iodoethyl)-4-chlorobenzene 、 3-甲氧基异硫氰酸苯酯 在 cesium fluoride 作用下， 以 neat (no solvent) 为溶剂， 反应 10.0h， 以60%的产率得到4-(4-chlorophenyl)-N-(3-methoxyphenyl)thiazol-2-amine
  参考文献：
  名称：

  Aryliodoazide Synthons：多样化合成 2-氨基噻唑、1,3-噻唑和 1,3-硒唑支架的不同方法。

  摘要：

  已经建立了几种直接且实用的方法来从芳基碘化物构建 2-氨基噻唑、1,3-噻唑和 1,3-硒唑。这些策略成功地使用了广泛的取代硫代酰胺及其衍生物，产生了以令人满意的产率获得的五元杂环。这些协议的独特之处在于操作简单和高度官能团耐受性，这使其成为制备各种 2-氨基噻唑、1,3-噻唑和 1,3-硒唑库的方便实用的途径。

  DOI：

  10.1021/acscombsci.9b00045

文献信息

• Compounds and Uses Thereof in Modulating Amyloid Beta
  申请人：Cheng Soan

  公开号：US20070260058A1

  公开（公告）日：2007-11-08

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  本发明提供了新的化合物、组合物和试剂盒。还提供了调节Aβ水平的方法以及治疗与异常Aβ水平相关的疾病的方法。
• COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
  申请人：Cheng Soan

  公开号：US20100324032A1

  公开（公告）日：2010-12-23

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  本发明提供了新型化合物、组合物和试剂盒。还提供了调节Aβ水平的方法和治疗与异常Aβ水平相关的疾病的方法。
• Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells
  作者：Breland Smith、Hui-Hua Chang、Federico Medda、Vijay Gokhale、Justin Dietrich、Angela Davis、Emmanuelle J. Meuillet、Christopher Hulme

  DOI：10.1016/j.bmcl.2012.03.013

  日期：2012.5

  This Letter presents the synthesis and biological evaluation of a collection of 2-aminothiazoles as a novel class of compounds with the capability to reduce the production of PGE(2) in HCA-7 human adenocarcinoma cells. A total of 36 analogs were synthesized and assayed for PGE(2) reduction, and those with potent cellular activity were counter screened for inhibitory activity against COX-2 in a cell free assay. In general, analogs bearing a 4-phenoxyphenyl substituent in the R-2 position were highly active in cells while maintaining negligible COX-2 inhibition. Specifically, compound 5l (R-1 = Me, R-2 = 4-OPh-Ph, R-3 = CH(OH)Me) exhibited the most potent cellular PGE(2) reducing activity of the entire series (EC50 = 90 nM) with an IC50 value for COX-2 inhibition of >5 mu M in vitro. Furthermore, the anti-tumor activity of analog 1a was analyzed in xenograft mouse models exhibiting promising anti-cancer activity. (C) 2012 Elsevier Ltd. All rights reserved.
• US7244739B2
  申请人：——

  公开号：US7244739B2

  公开（公告）日：2007-07-17
• US7781442B2
  申请人：——

  公开号：US7781442B2

  公开（公告）日：2010-08-24